Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Vanheel, Annelies ^a   Daniels, Ruth ^a   Plaisance, Stéphane ^b   Baeten, Kurt ^a   Hendriks, Jerome J A ^a   Leprince, Pierre ^c   Dumont, Debora ^a   Robben, Johan ^d   Brône, Bert ^a   Stinissen, Piet ^a   Noben, Jean Paul ^a   Hellings, Niels ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; 4 AMINOBUTYRATE AMINOTRANSFERASE; ALBUMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DEHYDROGENASE; MYELIN; NEUROTRANSMITTER; POSTSYNAPTIC DENSITY PROTEIN 95; REGULATOR PROTEIN; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CHANNEL GATING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; ENCEPHALITIS; FEMALE; MACROPHAGE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NERVE CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MEMBRANE PROTEINS; MULTIPLE SCLEROSIS; PRINCIPAL COMPONENT ANALYSIS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; RATS; RATS, INBRED LEW; REPRODUCIBILITY OF RESULTS;

ANIMALIA; RATTUS;

EID: 84859834399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035544     Document Type: Article

References (43)

1. Svejgaard A, (2008) The immunogenetics of multiple sclerosis. Immunogenetics 60: 275-286.
2. Ebers GC, (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268-277.
3. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, et al. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285.
4. Barnett MH, Prineas JW, (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55: 458-468.
5. Zipp F, (2009) A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes. J Neurol Sci 287 (Suppl 1): S24-29.
6. Cross AH, Trotter JL, Lyons J, (2001) B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112: 1-14.
7. Lassmann H, Bruck W, Lucchinetti CF, (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210-218.
8. Lau A, Tymianski M, (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 460: 525-542.
9. Pitt D, Werner P, Raine CS, (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6: 67-70.
10. Fountoulakis M, Tsangaris GT, Maris A, Lubec G, (2005) The rat brain hippocampus proteome. J Chromatogr B Analyt Technol Biomed Life Sci 819: 115-129.
11. Dasgupta B, Yi Y, Hegedus B, Weber JD, Gutmann DH, (2005) Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res 65: 9843-9850.
12. Lafon-Cazal M, Adjali O, Galeotti N, Poncet J, Jouin P, et al. (2003) Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J Biol Chem 278: 24438-24448.
13. Siman R, McIntosh TK, Soltesz KM, Chen Z, Neumar RW, et al. (2004) Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 16: 311-320.
14. Sironi L, Guerrini U, Tremoli E, Miller I, Gelosa P, et al. (2004) Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J Neurosci Res 78: 115-122.
15. Alt C, Duvefelt K, Franzen B, Yang Y, Engelhardt B, (2005) Gene and protein expression profiling of the microvascular compartment in experimental autoimmune encephalomyelitis in C57Bl/6 and SJL mice. Brain Pathol 15: 1-16.
16. Duzhak T, Emerson MR, Chakrabarty A, Alterman MA, Levine SM, (2003) Analysis of protein induction in the CNS of SJL mice with experimental allergic encephalomyelitis by proteomic screening and immunohistochemistry. Cell Mol Biol (Noisy-le-grand) 49: 723-732.
17. Liu T, Donahue KC, Hu J, Kurnellas MP, Grant JE, et al. (2007) Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Proteome Res 6: 2565-2575.
18. Tumani H, Lehmensiek V, Lehnert S, Otto M, Brettschneider J, (2010) 2D DIGE of the cerebrospinal fluid proteome in neurological diseases. Expert Rev Proteomics 7: 29-38.
19. Liu S, Bai S, Qin Z, Yang Y, Cui Y, et al. (2009) Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. J Cell Mol Med 13: 1586-1603.
20. Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, et al. (2009) CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci Lett 452: 214-217.
21. Qin Z, Qin Y, Liu S, (2009) Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell Mol Neurobiol 29: 203-210.
22. Lehmensiek V, Sussmuth SD, Tauscher G, Brettschneider J, Felk S, et al. (2007) Cerebrospinal fluid proteome profile in multiple sclerosis. Mult Scler 13: 840-849.
23. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, et al. (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451: 1076-1081.
24. Linker RA, Brechlin P, Jesse S, Steinacker P, Lee DH, et al. (2009) Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage. PLoS One 4: e7624.
25. Mikkat S, Lorenz P, Scharf C, Yu X, Glocker MO, et al. (2010) MS characterization of qualitative protein polymorphisms in the spinal cords of inbred mouse strains. Proteomics 10: 1050-1062.
26. Baeten K, Hendriks JJ, Hellings N, Theunissen E, Vanderlocht J, et al. (2008) Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging. J Neuroimmunol 195: 1-6.
27. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, et al. (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 107: 2580-2585.
28. Bhat R, Steinman L, (2009) Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64: 123-132.
29. Banati RB, Gehrmann J, Lannes-Vieira J, Wekerle H, Kreutzberg GW, (1995) Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied by a microglial expression of the beta A4-amyloid precursor protein (APP). Glia 14: 209-215.
30. Stornetta RL, Hawelu-Johnson CL, Guyenet PG, Lynch KR, (1988) Astrocytes synthesize angiotensinogen in brain. Science 242: 1444-1446.
31. Luhder F, Lee DH, Gold R, Stegbauer J, Linker RA, (2009) Small but powerful: short peptide hormones and their role in autoimmune inflammation. J Neuroimmunol 217: 1-7.
32. Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A, (2011) Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions. Hum Mol Genet.
33. Szewczyk A, Jarmuszkiewicz W, Kunz WS, (2009) Mitochondrial potassium channels. IUBMB Life 61: 134-143.
34. van Horssen J, Drexhage JA, Flor T, Gerritsen W, van der Valk P, et al. (2010) Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med 49: 1283-1289.
35. Zhu B, Luo L, Moore GR, Paty DW, Cynader MS, (2003) Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 162: 1639-1650.
36. Marouga R, David S, Hawkins E, (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382: 669-678.
37. Viswanathan S, Unlu M, Minden JS, (2006) Two-dimensional difference gel electrophoresis. Nat Protoc 1: 1351-1358.
38. Sizova D, Charbaut E, Delalande F, Poirier F, High AA, et al. (2007) Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis. Neurobiol Aging 28: 357-370.
39. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
40. Dumont D, Noben JP, Raus J, Stinissen P, Robben J, (2004) Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 4: 2117-2124.
41. Zellner M, Babeluk R, Diestinger M, Pirchegger P, Skeledzic S, et al. (2008) Fluorescence-based Western blotting for quantitation of protein biomarkers in clinical samples. Electrophoresis 29: 3621-3627.
42. Bogie JF, Stinissen P, Hellings N, Hendriks JJ, (2011) Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation. J Neuroinflammation 8: 85.
43. Imlach WL, Finch SC, Dunlop J, Meredith AL, Aldrich RW, et al. (2008) The molecular mechanism of "ryegrass staggers," a neurological disorder of K+ channels. J Pharmacol Exp Ther 327: 657-664.